Matthew Stiles Bowdish, MD
Allergy/Immunology · Roseville
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- Not verified
- Not the same as out of network.
- Office
- 1
- Since medical school
- 25 years
- Northeastern Ohio University College of Medicine, 2001
Offices
1 location · Sacramento Ear Nose and Throat Surgical and Medical Group Inc · 29 clinicians in this group
Hospitals listed: Sutter Medical Center, Sacramento. That is not proof they admit you there this week.
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Dr. Bowdish’s office at (916) 736-6644 to ask if they take your plan before you enroll.
California Medical Board record
Licence A92192 · Current
Licensed to practise in California · since 2005 · expires 2027-03-31 · Northeastern Ohio Universities College of Medicine.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
School, training and certification
What this clinician told their state board, medical school and everything before it. Only some states publish this, so nothing here means the state does not say, not that there was no training or certification.
Specialty certification
- American Board of Allergy and Immunology - Allergy and Immunology
Hospitals they work in
1 hospital
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Sutter Medical Center, SacramentoSacramento, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of Sutter Health, which runs 27 hospitals in 2 statesPatients rate it 3 of 5 · 79% would definitely recommend itOverall rating: 4 of 5 starsWorse than the national rate — Rate of inpatient admissions for patients receiving outpatient chemotherapy: 13.9 (12 to 15.9) · 992 cases, Jan 2024 – Dec 2024Better than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.066, Oct 2024 – Sep 2025Better than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.335, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.215, Oct 2024 – Sep 2025Better than the national rate — MRSA Bacteremia: 0.46, Oct 2024 – Sep 2025Better than the national rate — SSI - Colon Surgery: 0.253, Oct 2024 – Sep 2025
See every measure and the patient survey for Sutter Medical Center, Sacramento
Behind the star rating — Deaths: 0 better, 8 the same, 0 worse of 8 measures. Safety: 3 better, 5 the same, 0 worse of 8 measures. Readmissions: 0 better, 9 the same, 2 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 13.9 (12 to 15.9) · 992 cases | Worse | Jan 2024 – Dec 2024 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.066 | Better | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.335 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.215 | Better | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.46 | Better | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.253 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.12 (0.29 to 1.94) · 2,408 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.99 (0.78 to 1.2) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 166.68 (126.66 to 206.71) · 180 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2.4 · 292 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 7.7 · 143 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 10.2 · 359 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 11.8 · 543 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 15.9 · 425 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 10.4 · 441 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3 · 5,216 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.11 (0 to 0.29) · 9,948 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.28 (0.1 to 0.45) · 10,968 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.04 (1.53 to 4.56) · 3,983 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.33 (0.2 to 2.46) · 2,033 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.78 (1.69 to 3.87) · 3,594 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 9.79 (6.29 to 13.29) · 2,100 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 6.62 (4.04 to 9.2) · 2,018 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.63 (0.29 to 2.98) · 867 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.54 (0.07 to 1.01) · 8,613 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.3 · 294 cases | None | Apr 2023 – Mar 2025 |
| SSI - Abdominal HysterectomyInfections | 0 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 15.5 · 598 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 19.9 · 924 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 8.5 · 488 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -18.3 · 638 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 24.4 · 443 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 17.7 · 600 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 4.9 (3.9 to 6.1) · 992 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.1 · 298 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 9 · 249 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.6 · 250 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 11.3 (8.7 to 14.6) · 1,326 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1 (0.8 to 1.3) · 934 cases | No different | Jan 2024 – Dec 2024 |
What patients said (700 patients answered, 20% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 3 |
| Communication about medicines | 3 |
| Discharge information | 3 |
| Overall hospital rating | 4 |
| Quietness | 2 |
| Recommend hospital | 5 |
| Room was "always" clean | 76% |
| Nurses "always" communicated well | 80% |
| Doctors "always" communicated well | 79% |
| Staff "always" explained | 61% |
| Yes, staff "did" give patients this information | 86% |
| Yes, staff "did" give patients information about help after discharge | 84% |
| Doctors "always" explained things so they could understand | 75% |
| Doctors "always" listened carefully | 77% |
| Doctors "always" treated them with courtesy and respect | 84% |
| Patients who gave a rating of "9" or "10" (high) | 79% |
| Staff "always" explained new medications | 75% |
| Nurses "always" explained things so they could understand | 75% |
| Nurses "always" listened carefully | 78% |
| Nurses "always" treated them with courtesy and respect | 86% |
| "Always" quiet at night | 49% |
| "YES", patients would definitely recommend the hospital | 79% |
| Staff "always" explained possible side effects | 47% |
| Yes, staff "did" give patients information about possible symptoms | 87% |
Original Medicare doctor bills
$290,576
Medicare paid this office $290,576 for 413 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Professional service for preparation and provision of 1 or more antigens | 167 | $186,988 | $13 |
| Return visit (30+ min) | 183 | $29,318 | $100 |
| Professional service for multiple injections of allergen | 159 | $27,700 | $10 |
| Test for allergy using allergenic extract | 71 | $11,369 | $3 |
| New patient visit (45+ min) | 89 | $10,109 | $114 |
See all 12 services
| Professional service for preparation and provision of 1 or more antigens | 167 | $186,988 | $13 |
| Return visit (30+ min) | 183 | $29,318 | $100 |
| Professional service for multiple injections of allergen | 159 | $27,700 | $10 |
| Test for allergy using allergenic extract | 71 | $11,369 | $3 |
| New patient visit (45+ min) | 89 | $10,109 | $114 |
| Short return visit (20+ min) | 120 | $9,941 | $72 |
| Professional service for single injection of allergen | 30 | $2,701 | $8 |
| Test to measure expiratory airflow and volume | 77 | $2,376 | $23 |
| Test for allergy using allergenic extract injected into skin | 19 | $1,395 | $7 |
| Injection of drug or substance under skin or into muscle | 19 | $796 | $12 |
| Test to measure the level of nitric oxide gas | 24 | $475 | $17 |
| Administration and interpretation of patient-focused health risk assessment | 14 | $38 | $3 |
Who their Medicare patients are
413 Original Medicare patients in 2024. Average age 72 · Under 65 11% · 85 and older 6% · Women 69% · Also on Medicaid 17% · Health risk score 0.97. At or below the middle of the specialty; the typical allergy/ immunology clinician is at 1.
Conditions among them: High blood pressure 64% · Diabetes 23% · Depression 21% · Coronary heart disease 19% · COPD 18% · Chronic kidney disease 17% · Cancer 13% · Atrial fibrillation 13% · Heart failure 8% · Stroke 5%.
The office billed $903,047, Medicare allowed $378,802 and paid $290,576; for 23,264 services of 21 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 413 | 23,264 | 72 | 0.97 | $903,047 | $290,576 |
| 2023 | 406 | 13,595 | 72 | 0.89 | $530,612 | $162,771 |
| 2022 | 370 | 12,582 | 71 | 0.93 | $478,546 | $148,238 |
| 2021 | 407 | 13,614 | 71 | 0.87 | $549,059 | $178,395 |
| 2020 | 372 | 11,222 | 71 | 0.85 | $436,116 | $124,346 |
| 2019 | 408 | 14,275 | 70 | 0.87 | $545,654 | $154,056 |
| 2018 | 462 | 16,576 | 70 | 0.91 | $672,224 | $183,364 |
| 2017 | 417 | 9,903 | 71 | 0.97 | $350,919 | $111,460 |
| 2016 | 473 | 17,936 | 70 | 1.07 | $612,880 | $279,751 |
| 2015 | 652 | 27,979 | 70 | 1.02 | $1,169,065 | $445,955 |
| 2014 | 570 | 24,414 | 69 | 0.90 | $818,369 | $359,926 |
| 2013 | 593 | 30,201 | 70 | 0.99 | $1,073,842 | $465,347 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 12 services
| Professional service for preparation and provision of 1 or more antigens | 160 | $70,973 | $13 |
| Professional service for multiple injections of allergen | 164 | $27,682 | $9 |
| Return visit (30+ min) | 153 | $24,171 | $98 |
| New patient visit (45+ min) | 100 | $12,595 | $126 |
| Test for allergy using allergenic extract | 77 | $11,485 | $3 |
| Short return visit (20+ min) | 40 | $3,149 | $67 |
| Professional service for single injection of allergen | 28 | $2,371 | $7 |
| Test to measure expiratory airflow and volume | 62 | $1,650 | $21 |
| Test for allergy using allergenic extract injected into skin | 15 | $1,072 | $7 |
| Injection of drug or substance under skin or into muscle | 13 | $313 | $11 |
| Test to measure the level of nitric oxide gas | 16 | $275 | $15 |
| Administration and interpretation of patient-focused health risk assessment | 26 | $67 | $2 |
2022: 12 services
| Professional service for preparation and provision of 1 or more antigens | 166 | $71,790 | $13 |
| Professional service for multiple injections of allergen | 172 | $26,481 | $9 |
| Return visit (30+ min) | 110 | $17,436 | $98 |
| New patient visit (45+ min) | 73 | $8,848 | $121 |
| Test for allergy using allergenic extract | 60 | $8,823 | $3 |
| Short return visit (20+ min) | 50 | $4,101 | $68 |
| Professional service for single injection of allergen | 36 | $3,192 | $7 |
| Test for allergy using allergenic extract injected into skin | 22 | $1,734 | $7 |
| Test to measure expiratory airflow and volume | 55 | $1,337 | $22 |
| New patient visit (30+ min) | 14 | $1,177 | $84 |
| Test to measure the level of nitric oxide gas | 13 | $223 | $16 |
| Administration and interpretation of patient-focused health risk assessment | 35 | $94 | $2 |
2021: 11 services
| Professional service for preparation and provision of 1 or more antigens | 176 | $90,156 | $14 |
| Professional service for multiple injections of allergen | 178 | $28,404 | $9 |
| Return visit (30+ min) | 110 | $16,993 | $101 |
| New patient visit (45+ min) | 97 | $12,100 | $125 |
| Test for allergy using allergenic extract | 65 | $8,363 | $3 |
| Short return visit (20+ min) | 85 | $7,042 | $68 |
| Professional service for single injection of allergen | 38 | $3,490 | $7 |
| New patient visit (30+ min) | 17 | $1,328 | $78 |
| Test for allergy using allergenic extract injected into skin | 18 | $1,312 | $7 |
| Test to measure expiratory airflow and volume | 29 | $775 | $26 |
| Administration and interpretation of patient-focused health risk assessment | 53 | $162 | $2 |
2020: 11 services
| Professional service for preparation and provision of 1 or more antigens | 143 | $59,985 | $12 |
| Professional service for multiple injections of allergen | 155 | $18,862 | $8 |
| New patient visit (45+ min) | 85 | $11,061 | $130 |
| Return visit (30+ min) | 89 | $10,541 | $78 |
| Test for allergy using allergenic extract | 56 | $9,064 | $3 |
| Short return visit (20+ min) | 75 | $4,967 | $58 |
| Professional service for single injection of allergen | 37 | $2,975 | $7 |
| Test for allergy using allergenic extract injected into skin | 20 | $1,530 | $7 |
| Test to measure expiratory airflow and volume | 25 | $687 | $25 |
| Injection of drug or substance under skin or into muscle | 14 | $398 | $10 |
| Administration and interpretation of patient-focused health risk assessment | 47 | $120 | $2 |
2019: 16 services
| Professional service for preparation and provision of 1 or more antigens | 172 | $65,159 | $12 |
| Professional service for multiple injections of allergen | 193 | $24,953 | $8 |
| Test for allergy using allergenic extract | 77 | $13,206 | $3 |
| Return visit (30+ min) | 102 | $11,603 | $80 |
| New patient visit (45+ min) | 82 | $10,465 | $128 |
| Short return visit (20+ min) | 104 | $7,205 | $53 |
| Professional service for single injection of allergen | 51 | $4,401 | $7 |
| Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle | 11 | $4,215 | $64 |
| Test to measure expiratory airflow and volume | 103 | $3,514 | $28 |
| Test for allergy using allergenic extract injected into skin | 31 | $1,715 | $7 |
| Test for allergy using ingested items, initial 2 hours | 12 | $1,328 | $102 |
| Test for allergy using combination of methods with drug or biological | 11 | $1,215 | $18 |
| New patient visit (30+ min) | 14 | $1,175 | $84 |
| Test to measure largest amount of air breathed in an out | 20 | $684 | $22 |
| Injection of drug or substance under skin or into muscle | 14 | $519 | $14 |
| Administration and interpretation of patient-focused health risk assessment | 51 | $166 | $2 |
2018: 12 services
| Professional service for preparation and provision of 1 or more antigens | 201 | $66,877 | $11 |
| Professional service for multiple injections of allergen | 200 | $27,596 | $8 |
| Test for allergy using allergenic extract | 105 | $20,136 | $4 |
| Return visit (30+ min) | 132 | $16,304 | $81 |
| New patient visit (45+ min) | 116 | $13,103 | $113 |
| Short return visit (20+ min) | 161 | $11,110 | $52 |
| Test to measure expiratory airflow and volume | 131 | $4,438 | $29 |
| Professional service for single injection of allergen | 50 | $4,060 | $7 |
| Test to measure largest amount of air breathed in an out | 62 | $2,057 | $21 |
| Test for allergy using allergenic extract injected into skin | 35 | $1,590 | $7 |
| New patient visit (30+ min) | 22 | $1,271 | $58 |
| Administration and interpretation of patient-focused health risk assessment | 50 | $195 | $3 |
2017: 13 services
| Test for allergy using allergenic extract | 116 | $27,624 | $5 |
| Professional service for preparation and provision of 1 or more antigens | 61 | $23,857 | $11 |
| Short return visit (20+ min) | 202 | $14,546 | $56 |
| New patient visit (45+ min) | 86 | $10,967 | $128 |
| Professional service for multiple injections of allergen | 169 | $9,572 | $8 |
| Return visit (30+ min) | 88 | $8,831 | $83 |
| New patient visit (30+ min) | 58 | $4,851 | $84 |
| Test to measure expiratory airflow and volume | 103 | $2,994 | $28 |
| Test for allergy using allergenic extract injected into skin | 43 | $1,573 | $6 |
| Test to measure largest amount of air breathed in an out | 48 | $1,203 | $21 |
| Professional service for single injection of allergen | 34 | $1,113 | $7 |
| Administration of influenza virus vaccine | 17 | $456 | $27 |
| Influenza virus vaccine, not otherwise specified | 16 | $357 | $22 |
2016: 19 services
| Injection, omalizumab, 5 mg | 40 | $155,250 | None |
| Test for allergy using allergenic extract | 109 | $31,591 | $5 |
| Short return visit (20+ min) | 263 | $15,510 | $47 |
| Return visit (30+ min) | 143 | $12,755 | $68 |
| Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle | 42 | $12,648 | $56 |
| Professional service for preparation and provision of 1 or more antigens | 81 | $11,644 | $9 |
| New patient visit (30+ min) | 118 | $7,848 | $67 |
| Ct scan of face without contrast | 71 | $7,471 | $102 |
| Professional service for multiple injections of allergen | 46 | $5,499 | $7 |
| Test to measure expiratory airflow and volume | 151 | $5,433 | $25 |
| Professional service for single injection of allergen | 36 | $3,277 | $6 |
| Test for allergy using skin patch | 11 | $2,282 | $4 |
| Test for allergy using allergenic extract injected into skin | 40 | $2,123 | $6 |
| Test to measure expiratory airflow and volume changes before and after medication administration | 24 | $1,077 | $43 |
| Test to measure rate of airflow | 25 | $755 | $30 |
| Test to measure the level of nitric oxide gas | 31 | $472 | $15 |
| Injection of drug or substance under skin or into muscle | 13 | $232 | $18 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 11 | $51 | None |
| Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme | 11 | $1 | None |
2015: 21 services
| Injection, omalizumab, 5 mg | 47 | $235,563 | None |
| Test for allergy using allergenic extract | 187 | $49,304 | $5 |
| Short return visit (20+ min) | 437 | $36,485 | $50 |
| Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle | 50 | $20,577 | $56 |
| Return visit (30+ min) | 169 | $18,776 | $80 |
| Ct scan of face without contrast | 124 | $14,227 | $106 |
| New patient visit (30+ min) | 194 | $13,874 | $72 |
| Professional service for preparation and provision of 1 or more antigens | 70 | $13,312 | $9 |
| Test to measure expiratory airflow and volume | 251 | $12,672 | $27 |
| Professional service for multiple injections of allergen | 41 | $7,000 | $7 |
| Professional service for single injection of allergen | 38 | $5,293 | $6 |
| Test for allergy using allergenic extract injected into skin | 78 | $4,146 | $6 |
| Test for allergy using skin patch | 18 | $4,009 | $4 |
| Test to measure expiratory airflow and volume changes before and after medication administration | 46 | $2,143 | $46 |
| Test to measure the level of nitric oxide gas | 75 | $1,213 | $15 |
| Test to measure rate of airflow | 38 | $1,079 | $28 |
| Short return visit | 19 | $608 | $32 |
| Administration of influenza virus vaccine | 21 | $530 | $25 |
| Evaluation of use of breathing device | 19 | $272 | $14 |
| Influenza virus vaccine, not otherwise specified | 18 | $212 | $12 |
| Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme | 33 | $4 | None |
2014: 22 services
| Injection, omalizumab, 5 mg | 36 | $172,275 | None |
| Test for allergy using allergenic extract | 152 | $37,666 | $5 |
| Short return visit (20+ min) | 410 | $34,890 | $52 |
| Professional service for preparation and provision of 1 or more antigens | 63 | $28,725 | $9 |
| Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle | 38 | $16,358 | $56 |
| Ct scan of face without contrast | 88 | $13,689 | $143 |
| New patient visit (30+ min) | 170 | $12,100 | $71 |
| Test to measure expiratory airflow and volume | 205 | $8,900 | $26 |
| Professional service for multiple injections of allergen | 44 | $5,754 | $8 |
| Professional service for single injection of allergen | 34 | $4,785 | $6 |
| Test for allergy using allergenic extract injected into skin | 78 | $4,177 | $6 |
| Test for allergy using skin patch | 15 | $3,621 | $4 |
| Test to measure expiratory airflow and volume changes before and after medication administration | 53 | $2,525 | $46 |
| Return visit (30+ min) | 29 | $2,438 | $74 |
| New patient visit (45+ min) | 15 | $1,597 | $106 |
| Test to measure rate of airflow | 40 | $1,218 | $30 |
| Test to measure the level of nitric oxide gas | 58 | $935 | $15 |
| Administration of influenza virus vaccine | 30 | $766 | $25 |
| Short return visit | 18 | $553 | $29 |
| Influenza virus vaccine, split virus, when administered to individuals 3 years of age and older, for intramuscular use (fluzone) | 30 | $366 | $12 |
| Evaluation of use of breathing device | 18 | $244 | $13 |
| Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme | 45 | $7 | None |
2013: 25 services
| Injection, omalizumab, 5 mg | 42 | $241,341 | None |
| Test for allergy using allergenic extract | 157 | $42,615 | $5 |
| Short return visit (20+ min) | 410 | $36,898 | $52 |
| Professional service for preparation and provision of 1 or more antigens | 62 | $34,271 | $10 |
| Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle | 43 | $27,912 | $58 |
| Ct scan of face without contrast | 119 | $22,380 | $179 |
| New patient visit (30+ min) | 170 | $12,392 | $73 |
| Test to measure expiratory airflow and volume | 204 | $9,389 | $27 |
| Professional service for multiple injections of allergen | 62 | $5,496 | $8 |
| Test for allergy using allergenic extract injected into skin | 85 | $4,944 | $6 |
| Professional service for single injection of allergen | 51 | $4,043 | $7 |
| Return visit (30+ min) | 41 | $3,689 | $80 |
| Test for allergy using skin patch | 17 | $3,041 | $4 |
| Test to measure expiratory airflow and volume changes before and after medication administration | 54 | $2,667 | $48 |
| New patient visit (45+ min) | 14 | $1,663 | $119 |
| Test to measure rate of airflow | 36 | $1,099 | $31 |
| Short return visit | 26 | $881 | $33 |
| Test to measure the level of nitric oxide gas | 43 | $710 | $16 |
| Inhalation treatment for airway obstruction or sputum production | 45 | $680 | $15 |
| Administration of influenza virus vaccine | 18 | $484 | $25 |
| Injection of drug or substance under skin or into muscle | 23 | $422 | $18 |
| Evaluation of use of breathing device | 18 | $232 | $13 |
| Influenza virus vaccine, split virus, when administered to individuals 3 years of age and older, for intramuscular use (fluzone) | 17 | $213 | $12 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 23 | $86 | None |
| Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme | 52 | $9 | None |
Medicaid work
$113,171 in 2024
Medicaid paid $113,171 for 3,754 billed services this clinician did in 2024, up to 69 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| ANTIGEN THERAPY SERVICES | 274 | $63,161 |
| Return visit (30+ min) | 432 | $13,769 |
| New patient visit (45+ min) | 193 | $12,234 |
| Percutaneous tests (scratch, puncture, prick) with allergenic extracts, immediate type reaction, including test interpretation and report, specify number of tests | 201 | $10,268 |
| IMMUNOTHERAPY ONE INJECTION | 1,169 | $7,848 |
| Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); subcutaneous or intramuscular | 267 | $3,186 |
| Professional services for allergen immunotherapy not including provision of allergenic extracts; 2 or more injections | 1,127 | $1,045 |
| Short return visit (20+ min) | 51 | $974 |
| Spirometry, including graphic record, total and timed vital capacity, expiratory flow rate measurement(s), with or without maximal voluntary ventilation | 40 | $686 |
| 2024 | 3,754 | 9 | 69 | $113,171 |
| 2023 | 4,342 | 9 | 73 | $77,609 |
| 2022 | 5,186 | 9 | 85 | $174,049 |
| 2021 | 5,004 | 11 | 83 | $191,148 |
| 2020 | 3,728 | 11 | 60 | $134,972 |
| 2019 | 6,076 | 11 | 100 | $215,260 |
| 2018 | 6,284 | 12 | 102 | $251,646 |
See the largest Medicaid services in earlier years
2023
| ANTIGEN THERAPY SERVICES | 204 | $34,130 |
| Return visit (30+ min) | 490 | $12,667 |
| New patient visit (45+ min) | 148 | $6,119 |
| IMMUNOTHERAPY ONE INJECTION | 1,531 | $5,750 |
| Percutaneous tests (scratch, puncture, prick) with allergenic extracts, immediate type reaction, including test interpretation and report, specify number of tests | 194 | $5,710 |
| Short return visit (20+ min) | 199 | $5,380 |
| Professional services for allergen immunotherapy not including provision of allergenic extracts; 2 or more injections | 1,292 | $4,355 |
| Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); subcutaneous or intramuscular | 192 | $2,334 |
| Spirometry, including graphic record, total and timed vital capacity, expiratory flow rate measurement(s), with or without maximal voluntary ventilation | 92 | $1,165 |
2022
| ANTIGEN THERAPY SERVICES | 332 | $67,419 |
| Return visit (30+ min) | 686 | $44,862 |
| New patient visit (45+ min) | 354 | $25,133 |
| Percutaneous tests (scratch, puncture, prick) with allergenic extracts, immediate type reaction, including test interpretation and report, specify number of tests | 364 | $18,455 |
| IMMUNOTHERAPY ONE INJECTION | 1,896 | $7,460 |
| Professional services for allergen immunotherapy not including provision of allergenic extracts; 2 or more injections | 1,112 | $3,548 |
| Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); subcutaneous or intramuscular | 247 | $3,112 |
| Short return visit (20+ min) | 120 | $3,040 |
| Spirometry, including graphic record, total and timed vital capacity, expiratory flow rate measurement(s), with or without maximal voluntary ventilation | 75 | $1,022 |
2021
| ANTIGEN THERAPY SERVICES | 320 | $64,851 |
| Return visit (30+ min) | 574 | $42,388 |
| New patient visit (45+ min) | 344 | $30,732 |
| Percutaneous tests (scratch, puncture, prick) with allergenic extracts, immediate type reaction, including test interpretation and report, specify number of tests | 364 | $19,932 |
| Short return visit (20+ min) | 381 | $17,090 |
| IMMUNOTHERAPY ONE INJECTION | 1,858 | $7,329 |
| New patient visit (30+ min) | 42 | $4,108 |
| Professional services for allergen immunotherapy not including provision of allergenic extracts; 2 or more injections | 924 | $2,622 |
| Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); subcutaneous or intramuscular | 167 | $1,411 |
| Intracutaneous (intradermal) tests with allergenic extracts, immediate type reaction, including test interpretation and report, specify number of tests | 13 | $408 |
| Spirometry, including graphic record, total and timed vital capacity, expiratory flow rate measurement(s), with or without maximal voluntary ventilation | 17 | $277 |
2020
| ANTIGEN THERAPY SERVICES | 263 | $43,670 |
| Percutaneous tests (scratch, puncture, prick) with allergenic extracts, immediate type reaction, including test interpretation and report, specify number of tests | 293 | $31,551 |
| New patient visit (45+ min) | 252 | $23,150 |
| Return visit (30+ min) | 388 | $16,970 |
| Short return visit (20+ min) | 305 | $9,511 |
| IMMUNOTHERAPY ONE INJECTION | 1,157 | $4,899 |
| Spirometry, including graphic record, total and timed vital capacity, expiratory flow rate measurement(s), with or without maximal voluntary ventilation | 106 | $1,895 |
| New patient visit (30+ min) | 24 | $1,526 |
| Professional services for allergen immunotherapy not including provision of allergenic extracts; 2 or more injections | 808 | $1,077 |
| Maximum breathing capacity, maximal voluntary ventilation | 64 | $651 |
| Additional supplies, materials, and clinical staff time over and above those usually included in an office visit or other non-facility service(s), when performed during a Public Health Emergency, as defined by law, due to respiratory-transmitted infectious disease | 68 | $72 |
2019
| ANTIGEN THERAPY SERVICES | 333 | $54,462 |
| Percutaneous tests (scratch, puncture, prick) with allergenic extracts, immediate type reaction, including test interpretation and report, specify number of tests | 456 | $49,956 |
| New patient visit (45+ min) | 381 | $42,465 |
| Return visit (30+ min) | 543 | $29,862 |
| Short return visit (20+ min) | 421 | $11,478 |
| Spirometry, including graphic record, total and timed vital capacity, expiratory flow rate measurement(s), with or without maximal voluntary ventilation | 512 | $10,232 |
| IMMUNOTHERAPY ONE INJECTION | 1,414 | $5,924 |
| Chemotherapy administration, subcutaneous or intramuscular; non-hormonal anti-neoplastic | 94 | $3,988 |
| Professional services for allergen immunotherapy not including provision of allergenic extracts; 2 or more injections | 1,681 | $2,528 |
| Maximum breathing capacity, maximal voluntary ventilation | 213 | $2,402 |
| New patient visit (30+ min) | 28 | $1,964 |
2018
| ANTIGEN THERAPY SERVICES | 272 | $71,687 |
| Percutaneous tests (scratch, puncture, prick) with allergenic extracts, immediate type reaction, including test interpretation and report, specify number of tests | 550 | $53,040 |
| New patient visit (45+ min) | 364 | $47,197 |
| Return visit (30+ min) | 426 | $23,359 |
| Short return visit (20+ min) | 473 | $15,394 |
| Professional services for allergen immunotherapy not including provision of allergenic extracts; 2 or more injections | 2,791 | $13,223 |
| Spirometry, including graphic record, total and timed vital capacity, expiratory flow rate measurement(s), with or without maximal voluntary ventilation | 496 | $10,685 |
| New patient visit (30+ min) | 139 | $10,609 |
| Maximum breathing capacity, maximal voluntary ventilation | 206 | $2,776 |
| IMMUNOTHERAPY ONE INJECTION | 515 | $2,408 |
| Chemotherapy administration, subcutaneous or intramuscular; non-hormonal anti-neoplastic | 27 | $1,236 |
| Administration of patient-focused health risk assessment instrument (eg, health hazard appraisal) with scoring and documentation, per standardized instrument | 25 | $31 |
Drugs they prescribed that Part D paid
$1,064,544
Pharmacies billed $1,064,544 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 1,678) in 2024. At or below the middle of the specialty; the typical allergy/ immunology clinician is at 0%.
930 generic and 748 brand-name prescriptions · $1,064,544 in drug cost · 54 antibiotic prescriptions to 30 people.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Dupixent | None | 106 | $415,019 | $3,915 |
| Cuvitru | Immune globulin | 26 | $184,080 | $7,080 |
| Xolair | None | 41 | $135,321 | $3,301 |
| Trelegy Ellipta | None | 63 | $46,488 | $738 |
| Breo Ellipta | None | 56 | $22,195 | $396 |
See all 38 drugs
| Dupixent | None | 106 | $415,019 | $3,915 |
| Cuvitru | Immune globulin | 26 | $184,080 | $7,080 |
| Xolair | None | 41 | $135,321 | $3,301 |
| Trelegy Ellipta | None | 63 | $46,488 | $738 |
| Breo Ellipta | None | 56 | $22,195 | $396 |
| Breztri Aerosphere | None | 20 | $19,225 | $961 |
| Spiriva Respimat | None | 30 | $18,699 | $623 |
| Xhance | None | 13 | $13,167 | $1,013 |
| Epinephrine | None | 67 | $12,836 | $192 |
| Dulera | None | 26 | $8,669 | $333 |
| Azelastine-Fluticasone | None | 67 | $8,158 | $122 |
| Symbicort | None | 16 | $7,321 | $458 |
| Advair Hfa | None | 23 | $6,949 | $302 |
| Budesonide-Formoterol | None | 21 | $5,860 | $279 |
| Breyna | None | 23 | $5,684 | $247 |
| Arnuity Ellipta | None | 26 | $5,652 | $217 |
| Combivent Respimat | None | 11 | $5,640 | $513 |
| Albuterol Sulfate Hfa | None | 126 | $4,292 | $34 |
| Montelukast | None | 199 | $2,977 | $15 |
| Wixela Inhub | None | 14 | $2,789 | $199 |
| Diphenhydramine | None | 65 | $2,695 | $41 |
| Azelastine | None | 75 | $1,786 | $24 |
| Cromolyn | None | 12 | $1,551 | $129 |
| Ventolin Hfa | None | 21 | $1,289 | $61 |
| Ipratropium | None | 40 | $1,082 | $27 |
| Fluticasone Propionate | None | 37 | $586 | $16 |
| Levalbuterol Tartrate Hfa | None | 13 | $496 | $38 |
| Levocetirizine Dihydrochloride | None | 25 | $481 | $19 |
| Prednisone | None | 76 | $370 | $5 |
| Pantoprazole | None | 13 | $140 | $11 |
| Omeprazole | None | 11 | $130 | $12 |
| Triamcinolone Acetonide | None | 18 | $110 | $6 |
| Amoxicillin-Clavulanate Potass | None | 12 | $106 | $9 |
| Doxycycline Hyclate | None | 14 | $102 | $7 |
| Azithromycin | None | 19 | $70 | $4 |
| Methylprednisolone Sodium Succ | None | 13 | $61 | $5 |
| Ondansetron | None | 13 | $30 | $2 |
| Sodium Chloride | None | 12 | $27 | $2 |
Year by year
| 2024 | 1,678 | 276 | 0% (0) | 45% | $1,064,544 |
| 2023 | 1,338 | 233 | 0% (0) | None | $982,566 |
| 2022 | 1,368 | 237 | 0% (0) | None | $768,848 |
| 2021 | 1,609 | 301 | 0% (0) | 46% | $793,750 |
| 2020 | 1,297 | 264 | 0% (0) | 45% | $489,584 |
| 2019 | 1,198 | 242 | 0% (0) | 42% | $415,585 |
| 2018 | 1,144 | 255 | 0% (0) | 40% | $263,832 |
| 2017 | 673 | 218 | 0% (0) | 36% | $111,608 |
| 2016 | 1,081 | 201 | 0% (0) | 38% | $168,244 |
| 2015 | 988 | 227 | 0% (0) | 48% | $197,380 |
| 2014 | 739 | 176 | 0% (0) | 43% | $136,089 |
| 2013 | 817 | 182 | None | 40% | $184,923 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 34 drugs
| Dupixent | None | 62 | $229,972 | $3,709 |
| Cuvitru | Immune globulin | 17 | $115,452 | $6,791 |
| Xolair | None | 31 | $108,103 | $3,487 |
| Gamunex-C | Immune globulin | 25 | $105,330 | $4,213 |
| Nucala | None | 15 | $56,367 | $3,758 |
| Dupixent | None | 13 | $46,533 | $3,579 |
| Gammaplex | Immune globulin | 12 | $36,940 | $3,078 |
| Spiriva Respimat | None | 48 | $32,035 | $667 |
| Trelegy Ellipta | None | 29 | $31,915 | $1,101 |
| Symbicort | None | 46 | $27,631 | $601 |
| Breo Ellipta | None | 41 | $24,470 | $597 |
| Advair Diskus | None | 12 | $11,430 | $952 |
| Eucrisa | None | 13 | $9,026 | $694 |
| Epinephrine | None | 38 | $8,188 | $215 |
| Dulera | None | 20 | $7,001 | $350 |
| Azelastine-Fluticasone | None | 53 | $6,636 | $125 |
| Montelukast | None | 158 | $3,520 | $22 |
| Diphenhydramine | None | 65 | $3,410 | $52 |
| Albuterol Sulfate Hfa | None | 104 | $3,370 | $32 |
| Arnuity Ellipta | None | 11 | $2,754 | $250 |
| Azelastine | None | 49 | $2,604 | $53 |
| Zafirlukast | None | 13 | $2,048 | $158 |
| Ventolin Hfa | None | 23 | $1,926 | $84 |
| Levocetirizine Dihydrochloride | None | 28 | $1,250 | $45 |
| Ipratropium | None | 29 | $1,206 | $42 |
| Fluticasone Propionate | None | 50 | $1,044 | $21 |
| Hydroxyzine | None | 16 | $1,035 | $65 |
| Prednisone | None | 45 | $580 | $13 |
| Omeprazole | None | 11 | $307 | $28 |
| Triamcinolone Acetonide | None | 16 | $99 | $6 |
| Azithromycin | None | 15 | $73 | $5 |
| Methylprednisolone Sodium Succ | None | 12 | $56 | $5 |
| Dextrose in Water | None | 12 | $31 | $3 |
| Ondansetron | None | 11 | $25 | $2 |
2022: 33 drugs
| Xolair | None | 39 | $128,060 | $3,284 |
| Dupixent | None | 34 | $117,718 | $3,462 |
| Dupixent | None | 21 | $71,247 | $3,393 |
| Gamunex-C | Immune globulin | 32 | $58,329 | $1,823 |
| Nucala | None | 14 | $47,554 | $3,397 |
| Trelegy Ellipta | None | 48 | $36,325 | $757 |
| Spiriva Respimat | None | 51 | $36,029 | $706 |
| Breo Ellipta | None | 68 | $35,976 | $529 |
| Symbicort | None | 41 | $24,382 | $595 |
| Advair Diskus | None | 15 | $15,027 | $1,002 |
| Epinephrine | None | 33 | $12,366 | $375 |
| Advair Hfa | None | 16 | $9,650 | $603 |
| Incruse Ellipta | None | 21 | $9,465 | $451 |
| Stiolto Respimat | None | 13 | $6,341 | $488 |
| Budesonide-Formoterol | None | 12 | $5,850 | $488 |
| Dulera | None | 17 | $5,594 | $329 |
| Azelastine-Fluticasone | None | 39 | $5,247 | $135 |
| Cromolyn | None | 14 | $4,907 | $351 |
| Alvesco | None | 13 | $4,571 | $352 |
| Montelukast | None | 167 | $3,219 | $19 |
| Ventolin Hfa | None | 34 | $3,081 | $91 |
| Diphenhydramine | None | 57 | $2,702 | $47 |
| Albuterol Sulfate Hfa | None | 76 | $2,687 | $35 |
| Zafirlukast | None | 14 | $2,552 | $182 |
| Azelastine | None | 73 | $2,507 | $34 |
| Levocetirizine Dihydrochloride | None | 47 | $1,266 | $27 |
| Fluticasone Propionate | None | 61 | $905 | $15 |
| Ipratropium | None | 11 | $609 | $55 |
| Prednisone | None | 40 | $593 | $15 |
| Hydroxyzine | None | 17 | $86 | $5 |
| Famotidine | None | 14 | $63 | $4 |
| Dextrose in Water | None | 11 | $26 | $2 |
| Ondansetron | None | 11 | $26 | $2 |
2021: 39 drugs
| Xolair | None | 56 | $157,269 | $2,808 |
| Dupixent | None | 46 | $149,028 | $3,240 |
| Dupixent | None | 29 | $93,507 | $3,224 |
| Breo Ellipta | None | 86 | $46,223 | $537 |
| Symbicort | None | 73 | $45,023 | $617 |
| Spiriva Respimat | None | 53 | $40,359 | $761 |
| Trelegy Ellipta | None | 35 | $33,038 | $944 |
| Gamunex-C | Immune globulin | 17 | $25,901 | $1,524 |
| Privigen | Immune globulin | 12 | $16,750 | $1,396 |
| Advair Diskus | None | 21 | $15,325 | $730 |
| Budesonide-Formoterol | None | 28 | $12,316 | $440 |
| Epinephrine | None | 36 | $11,457 | $318 |
| Incruse Ellipta | None | 20 | $11,254 | $563 |
| Xhance | None | 12 | $10,150 | $846 |
| Dulera | None | 29 | $9,831 | $339 |
| Stiolto Respimat | None | 13 | $6,098 | $469 |
| Azelastine | None | 126 | $5,973 | $47 |
| Albuterol Sulfate Hfa | None | 78 | $4,550 | $58 |
| Cromolyn | None | 11 | $3,896 | $354 |
| Azelastine-Fluticasone | None | 28 | $3,750 | $134 |
| Olopatadine | None | 27 | $3,501 | $130 |
| Montelukast | None | 194 | $3,261 | $17 |
| Qnasl | None | 11 | $3,037 | $276 |
| Wixela Inhub | None | 15 | $2,687 | $179 |
| Diphenhydramine | None | 55 | $2,216 | $40 |
| Zafirlukast | None | 15 | $1,885 | $126 |
| Ventolin Hfa | None | 20 | $1,762 | $88 |
| Ipratropium | None | 24 | $1,226 | $51 |
| Mometasone Furoate | None | 15 | $1,135 | $76 |
| Levocetirizine Dihydrochloride | None | 54 | $978 | $18 |
| Fluticasone Propionate | None | 53 | $971 | $18 |
| Prednisone | None | 77 | $662 | $9 |
| Hydroxyzine | None | 19 | $539 | $28 |
| Clobetasol Propionate | None | 11 | $336 | $31 |
| Azithromycin | None | 16 | $153 | $10 |
| Fluconazole | None | 13 | $126 | $10 |
| Triamcinolone Acetonide | None | 11 | $80 | $7 |
| Ondansetron | None | 15 | $36 | $2 |
| Dextrose in Water | None | 13 | $32 | $2 |
2020: 33 drugs
| Xolair | 59 | $141,080 | $2,391 |
| Dupixent | 22 | $70,724 | $3,215 |
| Breo Ellipta | 77 | $30,056 | $390 |
| Symbicort | 59 | $28,544 | $484 |
| Spiriva Respimat | 43 | $24,583 | $572 |
| Advair Diskus | 25 | $17,314 | $693 |
| Dulera | 36 | $12,324 | $342 |
| Budesonide-Formoterol | 22 | $8,294 | $377 |
| Cromolyn | 15 | $8,233 | $549 |
| Epinephrine | 23 | $8,048 | $350 |
| Trelegy Ellipta | 13 | $7,634 | $587 |
| Wixela Inhub | 20 | $6,881 | $344 |
| Stiolto Respimat | 13 | $5,731 | $441 |
| Azelastine | 103 | $4,854 | $47 |
| Flovent Hfa | 12 | $4,368 | $364 |
| Qnasl | 16 | $4,115 | $257 |
| Azelastine-Fluticasone | 20 | $3,404 | $170 |
| Montelukast | 182 | $3,110 | $17 |
| Dymista | 14 | $2,930 | $209 |
| Ventolin Hfa | 31 | $2,408 | $78 |
| Albuterol Sulfate Hfa | 32 | $2,363 | $74 |
| Proair Hfa | 14 | $1,363 | $97 |
| Olopatadine | 22 | $1,120 | $51 |
| Fluticasone Propionate | 52 | $1,001 | $19 |
| Levocetirizine Dihydrochloride | 34 | $858 | $25 |
| Levalbuterol Tartrate Hfa | 12 | $729 | $61 |
| Ipratropium | 12 | $543 | $45 |
| Hydroxyzine | 18 | $492 | $27 |
| Prednisone | 54 | $354 | $7 |
| Triamcinolone Acetonide | 19 | $180 | $9 |
| Famotidine | 11 | $175 | $16 |
| Azithromycin | 23 | $133 | $6 |
| Dextrose in Water | 13 | $34 | $3 |
2019: 24 drugs
| Xolair | 60 | $141,941 | $2,366 |
| Symbicort | 71 | $34,796 | $490 |
| Spiriva Respimat | 39 | $19,964 | $512 |
| Breo Ellipta | 54 | $19,147 | $355 |
| Advair Diskus | 21 | $16,588 | $790 |
| Flovent Hfa | 25 | $9,821 | $393 |
| Dulera | 23 | $9,593 | $417 |
| Trelegy Ellipta | 11 | $7,293 | $663 |
| Stiolto Respimat | 14 | $5,956 | $425 |
| Azelastine | 105 | $5,322 | $51 |
| Dymista | 18 | $4,143 | $230 |
| Montelukast | 195 | $2,925 | $15 |
| Olopatadine | 22 | $2,486 | $113 |
| Proair Hfa | 20 | $2,060 | $103 |
| Ventolin Hfa | 23 | $1,766 | $77 |
| Levocetirizine Dihydrochloride | 37 | $1,183 | $32 |
| Mometasone Furoate | 13 | $868 | $67 |
| Fluticasone Propionate | 63 | $767 | $12 |
| Ipratropium | 16 | $749 | $47 |
| Methylprednisolone | 14 | $341 | $24 |
| Prednisone | 79 | $321 | $4 |
| Amoxicillin-Clavulanate Potass | 12 | $153 | $13 |
| Levofloxacin | 15 | $130 | $9 |
| Azithromycin | 13 | $87 | $7 |
2018: 21 drugs
| Xolair | 39 | $80,706 | $2,069 |
| Symbicort | 85 | $38,558 | $454 |
| Advair Diskus | 31 | $16,425 | $530 |
| Spiriva Respimat | 23 | $10,708 | $466 |
| Dulera | 29 | $10,425 | $359 |
| Breo Ellipta | 21 | $7,818 | $372 |
| Azelastine | 117 | $6,185 | $53 |
| Flovent Hfa | 18 | $4,416 | $245 |
| Dymista | 15 | $4,233 | $282 |
| Montelukast | 205 | $2,922 | $14 |
| Ventolin Hfa | 45 | $2,896 | $64 |
| Proair Hfa | 35 | $2,781 | $79 |
| Olopatadine | 19 | $2,370 | $125 |
| Ipratropium | 29 | $822 | $28 |
| Fluticasone Propionate | 56 | $761 | $14 |
| Levocetirizine Dihydrochloride | 22 | $438 | $20 |
| Levofloxacin | 24 | $317 | $13 |
| Prednisone | 78 | $258 | $3 |
| Desloratadine | 11 | $155 | $14 |
| Omeprazole | 12 | $106 | $9 |
| Azithromycin | 15 | $98 | $7 |
2017: 16 drugs
| Xolair | 12 | $22,652 | $1,888 |
| Symbicort | 59 | $22,214 | $377 |
| Advair Diskus | 17 | $8,002 | $471 |
| Spiriva Respimat | 16 | $7,865 | $492 |
| Dymista | 16 | $4,457 | $279 |
| Dulera | 14 | $4,042 | $289 |
| Azelastine | 62 | $3,177 | $51 |
| Montelukast | 134 | $1,663 | $12 |
| Proair Hfa | 21 | $1,560 | $74 |
| Ventolin Hfa | 11 | $898 | $82 |
| Ipratropium | 13 | $703 | $54 |
| Fluticasone Propionate | 49 | $678 | $14 |
| Doxycycline Hyclate | 11 | $316 | $29 |
| Levocetirizine Dihydrochloride | 19 | $238 | $13 |
| Prednisone | 46 | $210 | $5 |
| Azithromycin | 15 | $103 | $7 |
2016: 20 drugs
| Symbicort | None | 76 | $24,491 | $322 |
| Hizentra | Immune globulin | 12 | $21,146 | $1,762 |
| Advair Diskus | None | 21 | $11,121 | $530 |
| Spiriva | None | 19 | $7,651 | $403 |
| Dulera | None | 26 | $7,116 | $274 |
| Dymista | None | 24 | $6,792 | $283 |
| Breo Ellipta | None | 22 | $4,693 | $213 |
| Montelukast | None | 327 | $4,283 | $13 |
| Pataday | None | 19 | $3,834 | $202 |
| Azelastine | None | 64 | $2,941 | $46 |
| Pulmicort Flexhaler | None | 13 | $2,879 | $221 |
| Proair Hfa | None | 37 | $2,780 | $75 |
| Qnasl | None | 13 | $2,283 | $176 |
| Mometasone Furoate | None | 13 | $2,021 | $155 |
| Fluticasone Propionate | None | 121 | $1,582 | $13 |
| Cefdinir | None | 26 | $906 | $35 |
| Ipratropium | None | 12 | $227 | $19 |
| Ranitidine | None | 19 | $143 | $8 |
| Omeprazole | None | 12 | $87 | $7 |
| Prednisone | None | 14 | $56 | $4 |
2015: 21 drugs
| Hizentra | Immune globulin | 24 | $39,966 | $1,665 |
| Xolair | None | 12 | $35,309 | $2,942 |
| Symbicort | None | 90 | $28,464 | $316 |
| Spiriva | None | 41 | $13,045 | $318 |
| Dulera | None | 31 | $10,293 | $332 |
| Dymista | None | 57 | $10,275 | $180 |
| Montelukast | None | 269 | $5,606 | $21 |
| Nasonex | None | 24 | $5,524 | $230 |
| Epipen 2-Pak | None | 12 | $5,188 | $432 |
| Pataday | None | 20 | $3,464 | $173 |
| Qvar | None | 15 | $2,999 | $200 |
| Patanol | None | 12 | $2,987 | $249 |
| Advair Diskus | None | 11 | $2,864 | $260 |
| Proair Hfa | None | 35 | $2,207 | $63 |
| Azelastine | None | 34 | $1,740 | $51 |
| Cefdinir | None | 25 | $1,411 | $56 |
| Triamcinolone Acetonide | None | 16 | $610 | $38 |
| Fluticasone Propionate | None | 36 | $537 | $15 |
| Pantoprazole | None | 19 | $264 | $14 |
| Prednisone | None | 38 | $185 | $5 |
| Omeprazole | None | 14 | $135 | $10 |
2014: 16 drugs
| Privigen | Immune globulin | 12 | $18,820 | $1,568 |
| Symbicort | None | 47 | $15,651 | $333 |
| Spiriva | None | 29 | $9,642 | $332 |
| Montelukast | None | 254 | $7,015 | $28 |
| Nasonex | None | 37 | $6,680 | $181 |
| Dulera | None | 18 | $5,597 | $311 |
| Dymista | None | 25 | $3,785 | $151 |
| Advair Diskus | None | 12 | $3,688 | $307 |
| Qnasl | None | 25 | $3,213 | $129 |
| Pataday | None | 12 | $1,970 | $164 |
| Azelastine | None | 23 | $1,509 | $66 |
| Cefdinir | None | 30 | $1,268 | $42 |
| Fluticasone Propionate | None | 27 | $667 | $25 |
| Proair Hfa | None | 12 | $639 | $53 |
| Azithromycin | None | 15 | $146 | $10 |
| Prednisone | None | 20 | $125 | $6 |
2013: 16 drugs
| Xolair | None | 15 | $69,194 | $4,613 |
| Privigen | Immune globulin | 26 | $39,141 | $1,505 |
| Spiriva | None | 39 | $12,320 | $316 |
| Symbicort | None | 41 | $11,730 | $286 |
| Montelukast | None | 277 | $8,486 | $31 |
| Advair Diskus | None | 25 | $6,268 | $251 |
| Dulera | None | 21 | $4,848 | $231 |
| Nasonex | None | 25 | $3,987 | $159 |
| Qvar | None | 16 | $2,836 | $177 |
| Patanase | None | 14 | $2,299 | $164 |
| Azelastine | None | 23 | $1,876 | $82 |
| Qnasl | None | 14 | $1,700 | $121 |
| Cefdinir | None | 36 | $1,656 | $46 |
| Triamcinolone Acetonide | None | 16 | $1,329 | $83 |
| Fluticasone Propionate | None | 39 | $940 | $24 |
| Prednisone | None | 24 | $86 | $4 |
Money from drug and device companies
$2,188 in 2025
| 2025 | 19 | 93 | None | $2,188 |
| 2024 | 22 | 108 | $9,425 | $12,524 |
| 2023 | 23 | 95 | $9,025 | $12,705 |
| 2022 | 26 | 85 | $10,820 | $12,438 |
| 2021 | 21 | 74 | $22,930 | $25,365 |
| 2020 | 17 | 86 | $14,055 | $15,595 |
| 2019 | 23 | 153 | $34,222 | $39,648 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| AstraZeneca Pharmaceuticals LP | Fasenra | $497 | 13 payments
|
| Genzyme | Dupixent | $448 | 15 payments
|
| Cochlear Americas | Cochlear Nucleus Ci632 Cochlear Implant With Slim Modiolar Electrode | $310 | 2 payments
|
| CSL Behring | Hizentra | $189 | 8 payments
|
| Amgen | Tezspire | $150 | 7 payments
|
| Takeda Pharmaceuticals U.S.A. | Cuvitru | $112 | 5 payments
|
See all 71 published payments
| CSL Behring | Meals · 2025-12-17 | Hizentra | $33 |
| AstraZeneca Pharmaceuticals LP | Meals · 2025-12-16 | None | $19 |
| Novartis Pharmaceuticals | Meals · 2025-12-10 | Rhapsido | $26 |
| Genzyme | Meals · 2025-12-03 | Dupixent | $6 |
| Genzyme | Meals · 2025-12-02 | Dupixent | $10 |
| Amgen | Meals · 2025-12-01 | Tezspire | $17 |
| Cochlear Americas | Meals · 2025-11-20 | Cochlear Nucleus Ci632 Cochlear Implant With Slim Modiolar Electrode | $150 |
| Cochlear Americas | Meals · 2025-11-20 | Cochlear Nucleus Ci632 Cochlear Implant With Slim Modiolar Electrode | $160 |
| AstraZeneca Pharmaceuticals LP | Meals · 2025-11-19 | None | $24 |
| AstraZeneca Pharmaceuticals LP | Meals · 2025-11-12 | None | $21 |
| Takeda Pharmaceuticals U.S.A. | Meals · 2025-11-10 | Cuvitru | $20 |
| ARS Pharmaceuticals Operations | Meals · 2025-11-04 | Neffy | $17 |
| AstraZeneca Pharmaceuticals LP | Meals · 2025-10-30 | Fasenra | $15 |
| GlaxoSmithKline | Meals · 2025-10-29 | Nucala | $35 |
| Genzyme | Meals · 2025-10-22 | Dupixent | $28 |
| AstraZeneca Pharmaceuticals LP | Meals · 2025-10-21 | Fasenra | $18 |
| Novartis Pharmaceuticals | Meals · 2025-10-20 | None | $35 |
| Pharming Healthcare | Meals · 2025-10-15 | Ruconest | $18 |
| AstraZeneca Pharmaceuticals LP | Meals · 2025-10-08 | Fasenra | $22 |
| Genzyme | Meals · 2025-10-06 | Dupixent | $116 |
| Genzyme | Meals · 2025-09-30 | Dupixent | $12 |
| CSL Behring | Meals · 2025-09-17 | Hizentra | $29 |
| AstraZeneca Pharmaceuticals LP | Meals · 2025-09-16 | None | $14 |
| Lilly USA | Meals · 2025-09-10 | Taltz | $20 |
| Takeda Pharmaceuticals U.S.A. | Meals · 2025-09-03 | Cuvitru | $19 |
| Ionis Pharmaceuticals | Meals · 2025-08-25 | Dawnzera | $30 |
| Grifols USA | Meals · 2025-08-20 | Xembify | $27 |
| Regeneron Healthcare Solutions | Meals · 2025-08-13 | Dupixent | $25 |
| Arcutis Biotherapeutics | Meals · 2025-08-11 | Zoryve | $20 |
| Amgen | Meals · 2025-08-06 | Tezspire | $30 |
| Amgen | Meals · 2025-08-06 | Tezspire | $31 |
| CSL Behring | Meals · 2025-07-31 | Andembry | $30 |
| Amgen | Education · 2025-07-29 | None | $34 |
| Takeda Pharmaceuticals U.S.A. | Meals · 2025-07-28 | Cuvitru | $24 |
| Genzyme | Meals · 2025-07-24 | Dupixent | $74 |
| AstraZeneca Pharmaceuticals LP | Meals · 2025-07-23 | Fasenra | $18 |
| Organon | Meals · 2025-07-21 | Vtama | $25 |
| Galderma Laboratories L.P. | Meals · 2025-07-09 | Nemluvio | $19 |
| Takeda Pharmaceuticals U.S.A. | Education · 2025-06-25 | None | $16 |
| AstraZeneca Pharmaceuticals LP | Meals · 2025-06-23 | None | $15 |
| CSL Behring | Meals · 2025-06-18 | Hizentra | $24 |
| CSL Behring | Meals · 2025-06-02 | Hizentra | $12 |
| Genzyme | Meals · 2025-05-30 | Dupixent | $6 |
| Genzyme | Meals · 2025-05-29 | Dupixent | $110 |
| Genzyme | Meals · 2025-05-28 | Dupixent | $8 |
| Arcutis Biotherapeutics | Meals · 2025-05-28 | Zoryve | $17 |
| AstraZeneca Pharmaceuticals LP | Meals · 2025-05-27 | Tezspire | $135 |
| Genzyme | Meals · 2025-05-27 | Dupixent | $7 |
| AstraZeneca Pharmaceuticals LP | Meals · 2025-05-21 | None | $23 |
| Pharming Healthcare | Meals · 2025-04-30 | Ruconest | $15 |
| Amgen | Meals · 2025-04-23 | Actimmune | $28 |
| Novartis Pharmaceuticals | Meals · 2025-04-16 | Xolair | $16 |
| Genzyme | Meals · 2025-04-14 | Dupixent | $9 |
| Genzyme | Meals · 2025-04-09 | Dupixent | $19 |
| Genzyme | Education · 2025-04-09 | Dupixent | $8 |
| Viatris Specialty | Meals · 2025-04-02 | Yupelri | $15 |
| Optinose US | Meals · 2025-04-01 | Xhance | $15 |
| CSL Behring | Meals · 2025-03-26 | Hizentra | $24 |
| Takeda Pharmaceuticals U.S.A. | Meals · 2025-03-19 | Eohilia | $33 |
| Genzyme | Meals · 2025-03-05 | Dupixent | $29 |
| AstraZeneca Pharmaceuticals LP | Meals · 2025-03-03 | Fasenra | $15 |
| CSL Behring | Meals · 2025-02-26 | Haegarda | $18 |
| Amgen | Meals · 2025-02-25 | Tezspire | $5 |
| CSL Behring | Meals · 2025-02-24 | Hizentra | $18 |
| ARS Pharmaceuticals Operations | Meals · 2025-02-05 | Neffy | $28 |
| Amgen | Meals · 2025-01-28 | Tezspire | $6 |
| Lilly USA | Meals · 2025-01-23 | Ebglyss | $13 |
| Regeneron Healthcare Solutions | Meals · 2025-01-15 | Dupixent | $37 |
| Optinose US | Meals · 2025-01-08 | Xhance | $29 |
| Genzyme | Meals · 2025-01-06 | Dupixent | $4 |
| AstraZeneca Pharmaceuticals LP | Meals · 2025-01-02 | Fasenra | $158 |
See earlier years (2024, 2023, 2022, 2021, 2020, 2019)
2024: $12,524
| GlaxoSmithKline | Nucala | $10,555 | 15 payments
|
| Genzyme | Dupixent | $537 | 28 payments
|
| AstraZeneca Pharmaceuticals LP | Airsupra | $413 | 10 payments
|
| Takeda Pharmaceuticals U.S.A. | Cuvitru | $200 | 9 payments
|
| Genentech USA | Xolair | $130 | 1 payment
|
| Regeneron Healthcare Solutions | Dupixent | $122 | 1 payment
|
| CSL Behring | Hizentra | $76 | 3 payments
|
| Inspire Medical Systems | Inspire | $75 | 1 payment
|
| Pharming Healthcare | Ruconest | $71 | 3 payments
|
| Amgen | Tezspire | $62 | 2 payments
|
| Pfizer | Eucrisa | $38 | 2 payments
|
| Novartis Pharmaceuticals | Xolair | $31 | 1 payment
|
| Incyte | Opzelura | $29 | 1 payment
|
| Grifols USA | Xembify | $27 | 1 payment
|
| X4 Pharmaceuticals | Xolremdi | $25 | 1 payment
|
| Optinose US | Xhance | $24 | 1 payment
|
| Kedrion Biopharma | Albuked | $21 | 1 payment
|
| Octapharma USA | Cutaquig | $20 | 1 payment
|
| Mylan Specialty L.P. | Yupelri | $18 | 1 payment
|
| ALK-Abello | Odactra | $18 | 1 payment
|
| Boston Scientific | Wavewriter Alpha Prime 16 | $18 | 1 payment
|
| Phadia US | Immunocap | $15 | 1 payment
|
2023: $12,705
| GlaxoSmithKline | Nucala | $10,461 | 16 payments
|
| AbbVie | Rinvoq | $575 | 1 payment
|
| AstraZeneca Pharmaceuticals LP | Tezspire | $363 | 7 payments
|
| Genzyme | Dupixent | $267 | 14 payments
|
| Grifols USA | Xembify | $172 | 3 payments
|
| Regeneron Healthcare Solutions | Dupixent | $158 | 6 payments
|
| Bio Products Laboratory USA | Gammaplex | $104 | 5 payments
|
| CSL Behring | Haegarda | $92 | 3 payments
|
| Amgen | Tezspire | $92 | 4 payments
|
| Pfizer | Octagam Immune Globulin (Human) | $70 | 4 payments
|
| Takeda Pharmaceuticals U.S.A. | Cuvitru | $52 | 2 payments
|
| kaleo | Auvi-Q | $49 | 2 payments
|
| Genentech USA | Xolair | $34 | 1 payment
|
| Novartis Pharmaceuticals | Xolair | $28 | 1 payment
|
| Horizon Therapeutics plc | Actimmune | $27 | 1 payment
|
| LEO Pharma | Adbry | $26 | 1 payment
|
| Boehringer Ingelheim Pharmaceuticals | Spiriva | $21 | 1 payment
|
| Optinose US | Xhance | $20 | 1 payment
|
| Nestle Healthcare Nutrition | None | $20 | 1 payment
|
| Mylan Specialty L.P. | Yupelri | $19 | 1 payment
|
| BioCryst US Sales Co. | Orladeyo | $19 | 1 payment
|
| Blueprint Medicines | Ayvakit | $18 | 1 payment
|
| Octapharma USA | Cutaquig | $18 | 1 payment
|
2022: $12,438
| AstraZeneca Pharmaceuticals LP | Fasenra | $6,905 | 20 payments
|
| GlaxoSmithKline | Nucala | $2,687 | 10 payments
|
| Boehringer Ingelheim Pharmaceuticals | None | $1,920 | 2 payments
|
| Genentech | Xolair | $75 | 1 payment
|
| kaleo | Auvi-Q | $74 | 3 payments
|
| OptiNose US | Xhance | $71 | 2 payments
|
| Bio Products Laboratory USA | Gammaplex | $69 | 4 payments
|
| Regeneron Healthcare Solutions | Dupixent | $66 | 2 payments
|
| Takeda Pharmaceuticals U.S.A. | Takhzyro | $54 | 2 payments
|
| Genzyme | Dupixent | $50 | 2 payments
|
| CSL Behring | Hizentra | $45 | 2 payments
|
| Phadia US | Immunocap | $43 | 2 payments
|
| Abbvie | Rinvoq | $39 | 2 payments
|
| Novartis Pharmaceuticals | Xolair | $38 | 2 payments
|
| Grifols USA | Prolastin-C Liquid | $37 | 2 payments
|
| Genentech USA | Xolair | $33 | 1 payment
|
| Aimmune Therapeutics | Palforzia | $28 | 1 payment
|
| Pfizer | Panzyga | $27 | 1 payment
|
| LEO Pharma | Adbry | $27 | 1 payment
|
| Amgen | Tezspire | $26 | 1 payment
|
| Horizon Therapeutics plc | Actimmune | $25 | 1 payment
|
| Teva Pharmaceuticals USA | Airduo Digihaler | $24 | 1 payment
|
| ALK-Abello | Odactra | $24 | 1 payment
|
| Octapharma USA | Cutaquig | $19 | 1 payment
|
| Covis Pharma GmBH | Alvesco | $16 | 1 payment
|
| Mylan Specialty L.P. | Yupelri | $14 | 1 payment
|
2021: $25,365
| GlaxoSmithKline | Nucala | $20,845 | 25 payments
|
| Boehringer Ingelheim Pharmaceuticals | Spiriva Respimat | $2,946 | 7 payments
|
| AstraZeneca Pharmaceuticals LP | Fasenra | $1,006 | 11 payments
|
| Takeda Pharmaceuticals U.S.A. | Cuvitru | $82 | 4 payments
|
| Genentech | Xolair | $77 | 1 payment
|
| Genentech USA | Xolair | $74 | 4 payments
|
| Novartis Pharmaceuticals | None | $45 | 1 payment
|
| kaleo | Auvi-Q | $29 | 2 payments
|
| Pfizer | Cutaquig | $28 | 2 payments
|
| Teva Pharmaceuticals USA | Airduo Digihaler | $27 | 1 payment
|
| Regeneron Healthcare Solutions | Dupixent | $25 | 1 payment
|
| Horizon Therapeutics plc | Actimmune | $25 | 1 payment
|
| ALK-Abello | Odactra | $23 | 1 payment
|
| Optinose US | None | $21 | 1 payment
|
| Octapharma USA | Cutaquig | $20 | 1 payment
|
| BioCryst US Sales Co. | Orladeyo | $19 | 1 payment
|
| Merck Sharp & Dohme | None | $17 | 1 payment
|
| Genzyme | Dupixent | $17 | 1 payment
|
| Pharming Healthcare | Ruconest | $13 | 1 payment
|
| Blueprint Medicines | Ayvakit | $13 | 1 payment
|
| Philips Electronics North America | (8874) Incourage | $12 | 1 payment
|
2020: $15,595
| GlaxoSmithKline | Nucala | $4,975 | 16 payments
|
| AstraZeneca Pharmaceuticals LP | Fasenra | $3,539 | 17 payments
|
| OptiNose US | Xhance | $2,632 | 4 payments
|
| Boehringer Ingelheim Pharmaceuticals | Stiolto Respimat | $2,347 | 10 payments
|
| BioCryst Pharmaceuticals | None | $1,125 | 1 payment
|
| Octapharma USA | Cutaquig | $299 | 4 payments
|
| Regeneron Healthcare Solutions | Dupixent | $192 | 4 payments
|
| Takeda Pharmaceuticals U.S.A. | Cuvitru | $168 | 7 payments
|
| Teva Pharmaceuticals USA | Proair Digihaler | $87 | 4 payments
|
| CSL Behring | Hizentra | $72 | 4 payments
|
| Genzyme | Dupixent | $49 | 3 payments
|
| ALK-Abello | Odactra | $34 | 2 payments
|
| Pfizer | Eucrisa | $19 | 1 payment
|
| kaleo | Auvi-Q | $19 | 1 payment
|
| Boston Scientific | Superion | $13 | 1 payment
|
| Pharming Healthcare | Ruconest | $13 | 1 payment
|
| Mylan Specialty L.P. | Yupelri | $12 | 1 payment
|
2019: $39,648
| AstraZeneca Pharmaceuticals LP | Fasenra | $14,682 | 22 payments
|
| GlaxoSmithKline | Nucala | $12,622 | 18 payments
|
| Boehringer Ingelheim Pharmaceuticals | Stiolto Respimat | $5,107 | 15 payments
|
| Pharming Healthcare | Ruconest | $4,147 | 4 payments
|
| ALK-Abello | Odactra | $1,515 | 7 payments
|
| Novartis Pharmaceuticals | Xolair | $254 | 10 payments
|
| CSL Behring | Hizentra | $201 | 6 payments
|
| Shire North American Group | Cuvitru | $163 | 9 payments
|
| Regeneron Healthcare Solutions | Dupixent | $117 | 7 payments
|
| Octapharma USA | Cutaquig | $113 | 3 payments
|
| Kaleo | Auvi-Q | $109 | 5 payments
|
| Sunovion Pharmaceuticals | Lonhala Magnair | $107 | 11 payments
|
| Genzyme | Dupixent | $106 | 5 payments
|
| Genentech USA | Xolair | $90 | 4 payments
|
| Circassia Pharmaceuticals | Niox Vero | $77 | 4 payments
|
| Genentech | Xolair | $58 | 2 payments
|
| Teva Pharmaceuticals USA | Cinqair | $49 | 3 payments
|
| OptiNose US | Xhance | $46 | 2 payments
|
| Grifols USA | Prolastin-C Liquid | $23 | 1 payment
|
| Covis Pharma B.V. | Alvesco | $20 | 1 payment
|
| Advanced Respiratory | The Vest System Model 105 Home Care | $17 | 1 payment
|
| Greer Laboratories | Oralair | $14 | 1 payment
|
| Mylan Specialty L.P. | Yupelri | $12 | 1 payment
|
Checkups this office reported
Medicare did not publish checkup rates for this clinician.
- Medicare’s overall office score
- 69.2 / 100
- Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.
Professional record
- NPI
- 1770767923
- Licence
- CA A92192, CT 044700California A92192: Current · expires 2027-03-31
- Trained
- Northeastern Ohio University College of Medicine, 2001 · 25 years ago
- Video visits
- Lists video visits
- Gender
- Male
More record details
- Sole proprietor
- No
- Medicaid ID
- CA 100090065
- Taxonomy
- Federal specialty code 207K00000X (207K00000X)
- Mailing address
- 1111 Exposition Blvd Bldg 700, Sacramento, CA, 95815
- NPI first listed
- 2007-12-24
- NPI last updated
- 2023-04-18
- NPI record certified
- 2023-04-18
This is when the NPI record was last certified, not a medical board exam.
Extra NPI addresses: 6600 Mercy Ct Ste 180b, Fair Oaks, CA, 95628 · 785 Hana Way Ste 102, Folsom, CA, 95630 · 1111 Exposition Blvd Bldg 700, Sacramento, CA, 95815